As of 2025-07-05, the EV/EBITDA ratio of Amyris Inc (AMRS) is -1.81. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Amyris's latest enterprise value is 948 mil USD. Amyris's TTM EBITDA according to its financial statements is -523 mil USD. Dividing these 2 quantities gives us the above Amyris EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
Range | Selected | |
Trailing EV/EBITDA multiples | 8.4x - 10.0x | 10x |
Forward EV/EBITDA multiples | 9.3x - 13.0x | 10.8x |
Fair Price | (15.69) - (16.74) | (16.64) |
Upside | -31475.1% - -33571.0% | -33386.9% |
(USD in millions except Fair Price) | |||
Trailing | Forward | ||
Market Cap (USD mil) | EV/EBITDA | EV/EBITDA | |
Amyris Inc | 18 | N/A | N/A |
Balchem Corp | 5,383 | 23.2x | 20.2x |
Chase Corp | 1,212 | 11.2x | 17.6x |
Ferro Corp | 1,841 | 10.1x | 10.3x |
GCP Applied Technologies Inc | 2,369 | 20.2x | 16.2x |
Innospec Inc | 2,214 | 8.8x | 17.7x |
Quaker Chemical Corp | 2,197 | 10x | 10.8x |
Livent Corp | 2,970 | 5.9x | 4.9x |
Ingevity Corp | 1,705 | 7.8x | 7.8x |
TOR Minerals International Inc | 4 | 3.8x | 1.9x |
Industry median | 10x | 10.8x | |
(*) EBITDA | -523 | -523 | |
Enterprise value | (5,231) | (5,650) | |
(-) Net debt | 930 | 930 | |
Equity value | -6,161 | -6,579 | |
(/) Outstanding shares | 369 | 369 | |
Fair price | -17 | -18 | |